Related references
Note: Only part of the references are listed.Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI
Davide Capodanno et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2023)
Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI
Davide Capodanno et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2023)
Effect of an early invasive strategy based on time of symptom onset in patients with non-ST elevation myocardial infarction
S A Bae et al.
EUROPEAN HEART JOURNAL (2022)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
Management of Antithrombotic Therapy after Acute Coronary Syndromes
Fatima Rodriguez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Assessment of Pretreatment With Oral P2Y12 Inhibitors and Cardiovascular and Bleeding Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes A Systematic Review and Meta-analysis
Luke P. Dawson et al.
JAMA NETWORK OPEN (2021)
Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy Introduction
Filippo Crea
EUROPEAN HEART JOURNAL (2021)
Pre-treatment with dual antiplatelet therapy in non-ST-segment elevation acute coronary syndromes: landing from guidelines recommendations to real-world ground
Leonardo De Luca
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study
Boris Schnorbus et al.
EUROPEAN HEART JOURNAL (2020)
Patient and system delays in the treatment of acute coronary syndrome
Marta Viana et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2020)
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction Primary Results of the FABOLUS-FASTER Trial
Giuseppe Gargiulo et al.
CIRCULATION (2020)
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project
Emanuele Barbato et al.
EUROPEAN HEART JOURNAL (2020)
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
Giuseppe Tarantini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With Outcomes
Christian Dworeck et al.
JAMA NETWORK OPEN (2020)
Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes
Christian Valina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Pretreatment with P2Y12 receptor antagonists in ST-elevationmyocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry
Bjorn Redfors et al.
EUROPEAN HEART JOURNAL (2019)
Pre-Treatment With Oral P2Y12 Inhibitors in Acute Coronary Syndromes Without ST-Segment Elevation The Saga Continues
Davide Capodanno et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Results of the CANTIC Study
Francesco Franchi et al.
CIRCULATION (2019)
Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery
Juan J. Russo et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2019)
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
Davide Capodanno et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2019)
Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome VERDICT Randomized Controlled Trial
Klaus F. Kofoed et al.
CIRCULATION (2018)
Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials
Alexander Jobs et al.
LANCET (2017)
Precatheterization Use of P2Y12 Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry®
Marwan Badri et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?
Dirk Sibbing et al.
EUROPEAN HEART JOURNAL (2016)
Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study
Dariusz Dudek et al.
AMERICAN HEART JOURNAL (2015)
Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI The ACCOAST-PCI Study
Gilles Montalescot et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes
Gilles Montalescot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Delay From Symptom Onset to Hospital Presentation for Patients With Non-ST-Segment Elevation Myocardial Infarction
Henry H. Ting et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Time to Treatment for Acute Coronary Syndromes The Cost of Indecision
Holli A. DeVon et al.
JOURNAL OF CARDIOVASCULAR NURSING (2010)
Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE])
Robert J. Goldberg et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Pre-hospital delay in patients with acute coronary syndrome: Factors associated with patient decision time and home-to-hospital delay
Linda Perkins-Porras et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING (2009)
Platelet Inhibition with Cangrelor in Patients Undergoing PCI.
Robert A. Harrington et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)
Share Paper
